In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study.
about
Docking Screens for Novel Ligands Conferring New Biology.Identification of type I and type II inhibitors of c-Yes kinase using in silico and experimental techniques.Drug repurposing for chronic myeloid leukemia: in silico and in vitro investigation of DrugBank database for allosteric Bcr-Abl inhibitors.Structural, functional and molecular dynamics analysis of the native and mutated actin to study its effect on congenital myopathy.
P2860
In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
In-silico identification of in ...... lar dynamics simulation study.
@ast
In-silico identification of in ...... lar dynamics simulation study.
@en
type
label
In-silico identification of in ...... lar dynamics simulation study.
@ast
In-silico identification of in ...... lar dynamics simulation study.
@en
prefLabel
In-silico identification of in ...... lar dynamics simulation study.
@ast
In-silico identification of in ...... lar dynamics simulation study.
@en
P2093
P2860
P1476
In-silico identification of in ...... lar dynamics simulation study.
@en
P2093
Himansu Kumar
Saurabh Gupta
Utkarsh Raj
P2860
P304
P356
10.1080/07391102.2015.1110046
P577
2015-10-19T00:00:00Z